Background

Imogen works across the HIV and viral hepatitis research programs. She has a diverse background in program management and research with experience across public health, international health and biomedical research.

Since the completion of a PhD in cancer biology, Imogen has focused on international and public health, working in a range of settings including in Nepal, PNG and Indigenous Australian communities. She’s interested in innovative solutions that facilitate access and provision of health care services for vulnerable communities, and in improving health outcomes and equity through health system strengthening.

View all publications.

Positions

• 2019 - present: Research Program Manager, Burnet Institute
• 2018 - 2019: Program Manager, Victorian Comprehensive Cancer Centre
• 2016 - 2018: Research Fellow, University of Melbourne
• 2014 - 2016: International Clinical Research Fellow, Burnet Institute
• 2013 - 2014: Research and Evaluation Officer, Australia Youth Ambassador for Development, Nepal Network of Cancer Treatment and Research, Nepal
• 2011 - 2013: Postdoctoral Researcher, Peter MacCallum Cancer Centre

Qualifications

• 2018: MPH, Monash University
• 2011: PhD, University of Melbourne
• 2006: BSc (Hons) University of Melbourne
• 2005: BMedSc, Australian National University

Projects (3)

Current (3)

• 

  Ageing Well with HIV

• 

  EC Partnership: Eliminate Hepatitis C Partnership

• 

  The QuickStart Study

Publications (15)

2022 (1)

• Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study).
  O'Keefe D, Gunn J, Ryan K, Djordjevic F, Kerr P, Gold J, Elsum I, Layton C, Chan K, Dietze P, Higgs P, Doyle J, Stoové MA, Hellard M, Pedrana AE
  BMJ Open. 2022 Jan; 12(1):e057618

2021 (2)

• A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community-based testing campaign.
  Palmer AY, Chan K, Gold J, Layton C, Elsum I, Hellard M, Stoove M, Doyle JS, Pedrana A, Scott N; EC Partnership
  J Viral Hepat. 2021 Aug; 28(11):1624-1634
• Increasing hepatitis C testing and linkage to care: Results of a testing campaign with incentives at primary care clinics in Melbourne, Australia.
  Chan K, Elsum I, Gold J, Layton C, Accadia L, Bryant M, Gunn J, Djordjevic F, Purcell I, Dicka J, Forrest M, Crawford S, Hellard M, Pedrana A; Eliminate Hepatitis C Partnership
  J Viral Hepat. 2021 Jan; 28(3):569-572

2020 (1)

• A community-based co-designed genetic health service model for Aboriginal Australians.
  Imogen Elsum, Libby Massey, Callum McEwan, Desiree LaGrappe, Emma Kowal, Ravi Savarirayan, Gareth Baynam, Misty Jenkins, Gail Garvey, Margaret Kelaher
  PLoS One. 2020 Oct; 15(10):e0239765

2019 (1)

• Inclusion of Indigenous Australians in biobanks: a step to reducing inequity in health care.
  Imogen Elsum, Callum McEwan, Emma E Kowal, Yvonne Cadet-James, Margaret Kelaher, Lynn Woodward
  Med J Aust. 2019 Jul; 211(1):7-9.e1

2017 (2)

• High levels of transmitted HIV drug resistance in a study in Papua New Guinea.
  Lavu E, Kave E, Mosoro E, Markby J, Aleksic E, Gare J, Elsum IA, Nano G, Kaima P, Dala N, Gurung A, Bertagnolio S, Crowe SM, Myatt M, Hearps AC, Jordan MR
  PLoS One. 2017 Feb; 12(2):e0170265
• The Asymmetric Cell Division Regulators Par3, Scribble and Pins/Gpsm2 Are Not Essential for Erythroid Development or Enucleation.
  Christina B Wolwer, Nathan Godde, Luke B Pase, Imogen A Elsum, Krystle Y B Lim, Faruk Sacirbegovic, Carl R Walkley, Sarah Ellis, Shigeo Ohno, Fumio Matsuzaki, Sarah M Russell, Patrick O Humbert
  PLoS One. 2017 Jan; 12(1):e0170295

2014 (1)

• Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo.
  Elsum IA, Yates LL, Pearson HB, Phesse TJ, Long F, O'Donoghue R, Ernst M, Cullinane C, Humbert PO
  Oncogene. 2014 Nov; 33(48):5523-5533

2013 (2)

• Scribble regulates an EMT polarity pathway through modulation of MAPK-ERK signaling to mediate junction formation.
  Imogen A Elsum, Claire Martin, Patrick O Humbert
  J Cell Sci. 2013 Sep; 126(Pt 17):3990-3999
• Localization, not important in all tumor-suppressing properties: a lesson learnt from scribble.
  Elsum IA, Humbert PO
  Cells Tissues Organs. 2013 Jun; 198(1):1-11

2012 (1)

• The Scribble-Dlg-Lgl polarity module in development and cancer: from flies to man.
  Elsum I, Yates L, Humbert PO, Richardson HE
  Essays Biochem. 2012 Jul; 53:141-168

2011 (1)

• SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia.
  Pearson HB, Perez-Mancera PA, Dow LE, Ryan A, Tennstedt P, Bogani D, Elsum I, Greenfield A, Tuveson DA, Simon R, Humbert PO
  J Clin Invest. 2011 Nov; 121(11):4257-4267

2010 (1)

• Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.
  Godde NJ, Galea RC, Elsum IA, Humbert PO
  J Mammary Gland Biol Neoplasia. 2010 Jun; 15(2):149-168

2008 (2)

• Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module.
  Humbert PO, Grzeschik NA, Brumby AM, Galea R, Elsum I, Richardson HE
  Oncogene. 2008 Nov; 27(55):6888-6907
• Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling.
  Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, Humbert PO
  Oncogene. 2008 Oct; 27(46):5988-6001